EDIT vs. XLG
Compare and contrast key facts about Editas Medicine, Inc. (EDIT) and Invesco S&P 500® Top 50 ETF (XLG).
XLG is a passively managed fund by Invesco that tracks the performance of the Russell Top 50 Index. It was launched on May 10, 2005.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: EDIT or XLG.
Key characteristics
| EDIT | XLG | |
|---|---|---|
| YTD Return | -62.88% | 29.44% |
| 1Y Return | -40.22% | 44.88% |
| 3Y Return (Ann) | -53.86% | 13.04% |
| 5Y Return (Ann) | -29.07% | 19.15% |
| Sharpe Ratio | -0.56 | 2.93 |
| Sortino Ratio | -0.58 | 3.78 |
| Omega Ratio | 0.94 | 1.53 |
| Calmar Ratio | -0.43 | 3.81 |
| Martin Ratio | -0.92 | 15.82 |
| Ulcer Index | 45.13% | 2.72% |
| Daily Std Dev | 73.78% | 14.69% |
| Max Drawdown | -96.73% | -52.39% |
| Current Drawdown | -95.85% | 0.00% |
Correlation
The correlation between EDIT and XLG is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
EDIT vs. XLG - Performance Comparison
In the year-to-date period, EDIT achieves a -62.88% return, which is significantly lower than XLG's 29.44% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
EDIT vs. XLG - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Editas Medicine, Inc. (EDIT) and Invesco S&P 500® Top 50 ETF (XLG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
EDIT vs. XLG - Dividend Comparison
EDIT has not paid dividends to shareholders, while XLG's dividend yield for the trailing twelve months is around 0.74%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EDIT Editas Medicine, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XLG Invesco S&P 500® Top 50 ETF | 0.74% | 0.97% | 1.34% | 0.94% | 1.25% | 1.58% | 2.00% | 1.85% | 2.00% | 2.09% | 1.97% | 1.97% |
Drawdowns
EDIT vs. XLG - Drawdown Comparison
The maximum EDIT drawdown since its inception was -96.73%, which is greater than XLG's maximum drawdown of -52.39%. Use the drawdown chart below to compare losses from any high point for EDIT and XLG. For additional features, visit the drawdowns tool.
Volatility
EDIT vs. XLG - Volatility Comparison
Editas Medicine, Inc. (EDIT) has a higher volatility of 20.08% compared to Invesco S&P 500® Top 50 ETF (XLG) at 2.98%. This indicates that EDIT's price experiences larger fluctuations and is considered to be riskier than XLG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.